Log in to save to my catalogue

Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment

Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2187131637

Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment

About this item

Full title

Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2019-03

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Extracellular HMGB1 triggers inflammation following infection or injury, and supports tumorigenesis in inflammation-related malignancies. HMGB1 has several redox states: reduced HMGB1 recruits inflammatory cells to injured tissues forming a heterocomplex with CXCL12 and signaling via its receptor CXCR4; disulfide-containing HMGB1 binds to TLR4 and...

Alternative Titles

Full title

Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2187131637

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2187131637

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/563890